Strategic Advocates »

Cme shares owned by Strategic Advocates

Quarter-by-quarter ownership of Cme (CME) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Cme

Tip: Access up to 7 years of quarterly data

All positions including Cme held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cme by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2024-09-30 $403k 1.8k 220.65
2024-06-30 $277k 1.4k 196.60
2024-03-31 $271k 1.3k 215.29

More positions owned by Strategic Advocates

Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco Qqq Trust Series I Etf (QQQ)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Spdr Portfolio Long Term Corporate Bond Etf Etf (SPLB)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Nvidia Corporation Stock (NVDA)
Pimco 0-5 Year High Yield Corporate Bond Index Exchange-traded Fund Etf (HYS)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Apple Stock (AAPL)
Amazon Stock (AMZN)
Intuitive Surgical Stock (ISRG)
Meta Platforms Inc Cl A Stock (META)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for Strategic Advocates

Top funds holding Cme

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital World Investors
Jpmorgan Chase & Co
Geode Capital Management
Bank of New York Mellon
Morgan Stanley
T. Rowe Price Associates
Invesco
Northern Trust
Amundi
Vontobel Holding
Guardcap Asset Management

View all funds holding Cme